Letter to Editor | Volume 19: 45 | 17 Jul 2024

Reply to: Off-label use of repurposed ivermectin for SARS-Cov-2 infection should be banned by authorities unless efficacy is proven

Aina Amanina Abdul Jalil, Filza Nur Athirah Tar’ali

View in PMC Download

ABSTRACT

Abstract is not available. Click DOWNLOAD to read full text.